Prothionamide and capreomycin for tuberculosis
Author information unavailable
Abstract
Author information unavailable
Abstract
Tuberculosis is usually arrested by prolonged uninterrupted administration of a combination of isoniazid, sodium aminosalicylate (PAS) and streptomycin. Should this fail because of the emergence of drug-resistant organisms or intractable drug hypersensitivity, a combination including or entirely made up of ‘second-line’ drugs such as ethionamide, cycloserine, pyrazinamide, viomycin or kanamycin may be used. Two new ‘second-line’ drugs are prothionamide (Trevintix - M & B) and capreomycin (Dista).
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Tuberculosis is usually arrested by prolonged uninterrupted administration of a combination of isoniazid, sodium aminosalicylate (PAS) and streptomycin. Should this fail because of the emergence of drug-resistant organisms or intractable drug hypersensitivity, a combination including or entirely made up of ‘second-line’ drugs such as ethionamide, cycloserine, pyrazinamide, viomycin or kanamycin may be used. Two new ‘second-line’ drugs are prothionamide (Trevintix - M & B) and capreomycin (Dista).
Key concepts: Capreomycin, Ethionamide, Cycloserine, Pyrazinamide, Streptomycin, Viomycin, Isoniazid, Tuberculosis